27th April 2021
The Company acknowledges the independent report released on 1 March on “Global Data Exchange In Healthcare Market Forecast 2021-2028” and is pleased to be recognised among key trailblazers in the global digital health marketplace.
The Company remains under strict non-disclosure agreements. It is committed to and continues to make advances in its aims of delivering the best possible return for shareholders.
The Company continues to advance commercial negotiations to release the value of its remote monitoring DaaP. In addition to this the Company is exploring a separate commercially advantageous option with unrelated third parties.
The Company anticipates concluding these ongoing processes by early autumn. It will update the market as soon as possible and thanks shareholders for their continued patience.
All further updates will be published on www.cloudtag.com.